The conversation around artificial intelligence has shifted. A year ago, most businesses were debating whether to adopt AI.
The researchers took a “safety-first” approach. They deliberately excluded all viruses that infect humans or animals from the ...
Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...